Mesoporous polydopamine nanoparticles for tumor T1-T2 magnetic resonance imaging
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUN YAT SEN UNIV
- Publication Date
- 2021-05-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedical materials, and in particular relates to a mesoporous polydopamine nanoparticle used for tumor T1-T2 magnetic resonance imaging. Background technique
[0002] Magnetic resonance imaging (MRI) has attracted extensive attention due to its advantages of high temporal and spatial resolution, no limitation of penetration depth, and no radiation damage. Magnetic resonance contrast agents can enhance MRI signal by reducing the relaxation time of T1 or T2 water protons. T1 is called the longitudinal relaxation time, which is usually used to increase the visualization saturation and suppress the magnetic resonance signal intensity or imaging intensity. Since tissues usually have a long longitudinal relaxation time, T1-weighted images are suitable for observing adipose tissue or anatomical structures. T2 is called the transverse relaxation time, and the proton spin in the lesion usually has a longer rela...